Lipid Association Of India Issues New Updated Heart Disease Guidelines For Indian Patients

New Delhi: The Lipid Association of India (LAI) has updated its guidelines on heart disease in Indians, ToI reported on February 24.

The fresh guidelines include new data on cardiovascular risk assessment and lipid management, the report said.

Under the new guidelines, patients have been categorised into different risk groups, Dr Raman Puri, a cardiologist and founder chairman of LAI, told the newspaper.

The guidelines suggest that individuals with metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) should aim for LDL cholesterol levels below 70 mg/dL.

Furthermore, a new category called ‘Extreme Risk Group Category C’ has been introduced for a small number of patients who continue to experience chest pain despite all available treatments.

For individuals in this category, LDL cholesterol levels should ideally range between 10-15 mg/dL, as stated by Dr Vinod M Vijan, an interventional cardiologist.

LAI has been advocating for regular lipid profile screenings from the age of 20, and from the age of two for those with a family history of high cholesterol or premature coronary heart disease in men under 55 years and women under 65 years.

In cases of adopted children or families with elevated lipoprotein (a), lipid profile screenings should commence at the age of two, or as early as possible if not feasible, according to Dr Puri.

The new guidelines also recommend including lipoprotein (a) assessment in lipid profile tests for initial screening, as it is highly prevalent among 25 percent of Indians.

Related Posts

Lupin launches Ipratropium Bromide nasal spray in US

Pharma major Lupin Ltd on Friday said it has launched Ipratropium Bromide nasal spray, used in treatment of runny nose, in the US market. The Ipratropium Bromide nasal solution (nasal…

12 dead, 13 workers rescued as reactor blast rips through pharma unit near Hyderabad

Bodies of 12 workers were brought out and 13 others were rescued from under the debris after a blast in a reactor unit at Sigachi Industries Pvt. Ltd. in the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

HC-ordered expert panel for weight loss drug may be set up by mid-July

HC-ordered expert panel for weight loss drug may be set up by mid-July